← Leaderboards
Trevor P. Castor
Aphios Corporation
$13,674,664
Attributed
$15,648,444
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,648,444 · 20
By mechanism
R44$9,504,147 · 4
R43$4,965,435 · 14
RC1$920,464 · 1
R41$258,398 · 1
Top collaborators
- Washingtone Ochieng3 shared
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPharmacologic SubstanceDesignTechnologyLiquid SubstanceClinical TrialsIn VivoMedicalLicensingPharmacologySolventsAnimal ModelAcquired Immunodeficiency SyndromeInstitutesMeetingsBaseProgramsEngineeringResearch PersonnelCyclic GmpIn VitroCostResearch And DevelopmentProperty
Grant awards (31)
Botanical Drug for Chemotherapy Induced Nausea and Vomiting$416,134
R43 · FY2025 · AT · contact PI
Development of a Novel Alzheimer's Disease Therapeutic$504,732
R43 · FY2024 · AG · contact PI
Double-Encapsulated mRNA Vaccine for COVID-19$300,000
R43 · FY2024 · AI · contact PI
Combination Therapeutic for Chronic Opioid Use Disorder Relapse$335,700
R43 · FY2023 · DA · contact PI
Double-Encapsulated mRNA Vaccine for COVID-19$300,000
R43 · FY2023 · AI · contact PI
CFI Pathogen Inactivation of Human Plasma Units$1,789,666
R44 · FY2020 · HL · contact PI
CFI Pathogen Inactivation of Human Plasma Units$1,558,277
R44 · FY2019 · HL · contact PI
CFI Pathogen Inactivation of Human Plasma Units$599,617
R44 · FY2018 · HL · contact PI
Purging Latent HIV Reservoirs through a Combination HIV Therapeutic$575,354
R43 · FY2017 · AI · contact PI
Purging Latent HIV Reservoirs through a Combination HIV Therapeutic$50,000
R43 · FY2017 · AI · contact PI
Development of cGMP Manufacturing Process for CBD$742,149
R44 · FY2016 · DA · contact PI
Purging Latent HIV Reservoirs through a Combination HIV Therapeutic$463,205
R43 · FY2016 · AI · contact PI
Development of cGMP Manufacturing Process for CBD$742,149
R44 · FY2015 · DA · contact PI
Development of SFS Fractionators$224,947
R43 · FY2014 · AT · contact PI
Development of cGMP Manufacturing Process for CBD$224,841
R44 · FY2014 · DA · contact PI
Alzheimer's Disease Therapeutic$1,183,503
R44 · FY2012 · AG · contact PI
Alzheimer's Disease Therapeutic$1,202,600
R44 · FY2011 · AG · contact PI
Alzheimer's Disease Therapeutic$463,690
R44 · FY2010 · AG · contact PI
CFI Pathogen Inactivation Technology$420,464
RC1 · FY2010 · HL · contact PI
CFI Pathogen Inactivation Technology$500,000
RC1 · FY2009 · HL · contact PI
CFI Inactivation of Human Plasma$344,267
R43 · FY2009 · HL · contact PI
D9-THC for Marijuana Addiction$109,761
R43 · FY2008 · DA · contact PI
Alkylating Vitamin D Derivative$258,398
R41 · FY2007 · CA · contact PI
Anti-Smallpox Therapeutics from Marine Micoorganisms$264,705
R43 · FY2003 · AT
Development of a Natural Cannabinoid Product$234,783
R43 · FY2002 · CA
METHOD FOR MAKING AN IMPROVED ST JOHN'S WORT PRODUCT$505,990
R44 · FY2001 · AT
METHOD FOR MAKING AN IMPROVED ST JOHN'S WORT PRODUCT$491,665
R44 · FY2000 · AT
DEVELOPMENT OF A CONTROLLED RELEASE HIV VACCINE ADJUVANT$297,560
R43 · FY2000 · AI
DEVELOPMENT OF AN IMPROVED VIRUS-FREE FIBRIN GLUE$244,920
R43 · FY2000 · GM
STANDARDIZED AND IMPROVED SAW PALMETTO PRODUCT$150,000
R43 · FY2000 · AT
DEVELOPMENT OF A MARINE ANTI-PLAQUE COMPOUND$149,367
R43 · FY2000 · DE